Trial intelligence / Profile preview

Anesthesia Type and Quality of Recovery in Nephrectomy

NCT04521556Phase 4Completed

Sponsor
Clinical Hospital Center Split
Start
Apr 2019
Primary completion
Apr 2021
Modality
Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
Countries
1
01

Overview

A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection, morphine, tramadol in postoperative pain, sponsored by Clinical Hospital Center Split. Started Apr 2019; status: completed.

02

Drugs

ropivacaine hydrochloride liposomal suspension injectionmorphinetramadol
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04521556.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04521556.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call